Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.
Click here for original story, After treatment with semaglutide, newly diagnosed Type 1 diabetes patients needed little or no insulin
Source: ScienceDaily